Multimodality therapy for head and neck cancer

Veterinary Clinics of North America - Small Animal Practice

Volumn 33, Issue 3, 2003, Pages 615-628

  Klein, Mary K ^a  

^a Southwest Veterinary Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CETUXIMAB; CHIMERIC ANTIBODY; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DNA VACCINE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR BLOCKING AGENT; ETANIDAZOLE; FLUOROURACIL; GEMCITABINE; GLYCOPROTEIN; IMMUNOMODULATING AGENT; MEMBRANE PROTEIN; MITOXANTRONE; MONOCLONAL ANTIBODY; MONOPHENOL MONOOXYGENASE; MURAMYL TRIPEPTIDE; ONCOPROTEIN; PACLITAXEL; RADIOPROTECTIVE AGENT; RADIOSENSITIZING AGENT; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL DISEASE; ANTINEOPLASTIC ACTIVITY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CAT; DOG; DRUG FORMULATION; DRUG POTENTIATION; EAR TUMOR; GENE THERAPY; HEAD AND NECK CANCER; HUMAN; MELANOMA; METASTASIS; MORBIDITY; MOUTH TUMOR; MULTIMODALITY CANCER THERAPY; NONHUMAN; NOSE CARCINOMA; REVIEW; SALIVARY GLAND TUMOR; SQUAMOUS CELL CARCINOMA; THYROID TUMOR; VETERINARY MEDICINE;

ANIMALIA; CANIS FAMILIARIS; FELIDAE; FELIS CATUS;

EID: 0038756378     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(03)00018-4     Document Type: Review

References (86)

1. Holmberg DL, Fries C, Cockshutt J, et al. Ventral rhinotomy in the dog and cat. Vet Surg 1989;18:446-9.
2. Laing EJ, Binnington AG. Surgical therapy of canine nasal tumors. A retrospective study (1982-1986). Canine Vet 1988;29:809-13.
3. MacEwen EG, Withrow SJ, Patnaik AK. Nasal tumors in the dog: retrospective evaluation of diagnosis, prognosis and treatment. JAVMA 1977;170:45-8.
4. Madewell BR, Priester WA, Gillette EL, et al. Neoplasms of the nasal passages and paranasal sinuses in domestic animals as reported by 13 veterinary colleges. Am J Vet Res 1976;37:851-6.
5. Norris AM. Intranasal neoplasms in the dog. J Am Anim Hosp Assoc 1979;15:231-6.
6. Adams WM, Withrow SJ, Walshaw R, et al. Radiotherapy of malignant nasal tumors in 67 dogs. JAVMA 1987;191:311-5.
7. Adams WM, Miller PE, Vail DM, et al. An accelerated technique for irradiation of malignant canine nasal and paranasal sinus tumors. Vet Radiol Ultrasound 1998;39:475-81.
8. Evans SM, Goldschmidt M, McKee LF, et al. Prognostic factors and survival after radiotherapy for intranasal neoplasm in dogs: 70 cases (1974-1985). JAVMA 1989;194: 1460-63.
9. McEntee MC, Page RL, Heidner GL, et al. A retrospective study of 27 dogs with intranasal neoplasms treated with cobalt radiation. Vet Radiol Ultrasound 1991;32:135-9.
10. Theon AP, Madewell BR, Harb MF, et al. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs. JAVMA 1993;202:1469-75.
11. Thrall DE, Robertson ID, McLeod DA, et al. A comparison of radiographic and computed tomographic findings in 31 dogs with malignant nasal cavity tumors. Vet Radiol Ultrasound 1989;30:59-66.
12. Roberts SM, Lavach JD, Severin GA, et al. Ophthalmic complications following megavoltage irradiation of the nasal and paranasal cavities in dogs. JAVMA 1987; 100:43-7.
13. Park RD, Beck ER, LeCouteur RA. Comparison of computed tomography and radiography for detecting changes induced by malignant nasal neoplasia in dogs. JAVMA 1992;201:1720-4.
14. Thrall DE, Heidner GL, Novotney CA, et al. Failure patterns following cobalt irradiation in dogs with nasal carcinoma. Vet Radiol Ultrasound 1993;34:295-300.
15. Schantz SP, Harrison LB, Forastiere AA. Cancer of the head and neck: tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 6th edition. Philadelphia: Lippincott Williams&Wilkins; 2001. p. 797-860.
16. LaDue TA, Dodge R, Page RL, et al. Factors influencing survival after radiotherapy of nasal tumors in 130 dogs. Vet Radiol Ultrasound 1999;40:312-7.
17. Antonadou D, Pepelassi M, Synodinou M, et al. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;52:739-47.
18. 192Iridium brachytherapy, using an intracavitary afterload device, for treatment of intranasal neoplasms in dogs. Am J Vet Res 1992;53:617-22.
19. White R, Walker M, Legendre AM, et al. Development of brachytherapy technique for nasal tumors in dogs. Am J Vet Res 1990;51:1250-6.
20. Pajak TF, Laramore GE, Marcial VA, et al. Elapsed treatment days-a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 1991;20:13-20.
21. Fu KK, Phillips TL. Biologic rationale of combined radiotherapy and chemotherapy. Hematol Oncol Clin North Am 1991;5:737-51.
22. Choy H, Rodriguez FF, Loester S, et al. Investigation of Taxol as a potential radiation sensitizer. Cancer 1993;71(Suppl 11):3774-8.
23. Douple EB, Richmond RC, O'Hara JA, et al. Carboplatin as a potentiator or radiation therapy. Cancer Treat Rev 1985;12(Suppl A):111-24.
24. Mason KA, Milas L, Hunter NR, et al. Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys 1999,44:1125-35.
25. Havlin KA, Huhn JG, Myers JW, et al. High-dose cisplatin for locally advanced or metastatic head and neck cancer: a phase II pilot study. Cancer 1989;63:423-7.
26. Hahn KA, Knapp DW, Richardson RC, et al. Clinical response of nasal adenocarcinoma to cisplatin chemotherapy in 11 dogs. JAVMA 1992;200:355-7.
27. Al-Sarraf M. Management strategies in head and neck cancer: the role of carboplatin. In: Bunn PA, Jr, Canetta R, Ozols PF, et al, editors. Carboplatin: current perspectives and future directions. Philadelphia: WB Saunders, 1990. p. 221-31.
28. Browman GP, Cronin L. Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials. Semin Oncol 1994;21:311-9.
29. Al-Sarraf M, LeBlanc M, Shanker Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer. Phase III Randomized Intergroup Study 0099. J Clin Oncol 1998;16:1310-7.
30. Cooper JS, Lee H, Torrey M, et al. Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx. Preliminary corroboration of the Intergroup experience. Int J Radiat Oncol Biol Phys 2000;47:861-6.
31. Lana SE, Dernell WS, LaRue SM, et al. Slow release cisplatin combined with radiation for the treatment of canine nasal tumors. Vet Radiol Ultrasound 1997;38:474-8.
32. Mauldin GN, Meleo KA. Combination carboplatin and radiotherapy for nasal tumors in dogs [abstract]. In: Proceedings of the 14th Annual Conference of the Veterinary Cancer Society. Spring Valley (CA): Veterinary Cancer Society; 1994. p. 129.
33. Henry CJ, Brewer WG, Tyler JW, et al. Survival in dogs with nasal adenocarcinoma: 64 cases (1981-1995). J Vet Intern Med 1998;12:436-9.
34. Tennvall J, Lundell G, Wahlberg P, et al. Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 2002; 86:1848-53.
35. Jones PD, Kitchell BE, Losonsky JM. Gemcitabine as a radiosensitizer for non-resectable feline oral squamous cell carcinoma [abstract]. In: Proceedings of the 21st Annual Conference of the Veterinary Cancer Society, Baton Rouge. Spring Valley (CA): Veterinary Cancer Society; 2001. p. 36.
36. LaDue TA. In: Proceedings of the American College of Veterinary Radiology, Chicago; 2002 [abstract].
37. Withrow SJ. Cancer of the gastrointestinal tract A. Cancer of the oral cavity. In: Withrow SJ, MacEwen EG, editors. Small animal clinical oncology. 3rd edition. Philadelphia: WB Saunders; 2001. p. 305-18.
38. Bradley RL, MacEwen EG, Loar AS. Mandibular resection for removal of oral tumors in 30 dogs and 6 cats. JAVMA 1984;184:460-3.
39. Langham RF, Mostosky UV, Schirmer RG. X-ray therapy of selected odontogenic neoplasms in the dog. JAVMA 1977;170:820-2.
40. Salisbury SK, Richardson DC, Lantz GC. Partial maxillectomy and premaxillectomy in the treatment of oral neoplasia in the dog and cat. Vet Surg 1986;15:16-26.
41. Salisbury SK, Lantz GC. Long-term results of partial mandibulectomy for treatment of oral tumors in 30 dogs. J Am Anim Hosp Assoc 1988;24:285-94.
42. Thrall DE. Orthovoltage radiotherapy of acanthomatous epulides in 39 dogs. JAVMA 1984;184:826-9.
43. Wallace J, Matthiesen DT, Patnaik AK. Hemimaxillectomy for the treatment of oral tumors in 69 dogs. Vet Surg 1992;21:337-41.
44. Forrest LJ, Chun R, Adams WM, Cooley AJ, Vail DM. Postoperative radiotherapy for canine soft tissue sarcoma. J Vet Intern Med 2000;14:578-82.
45. McChesney S, Withrow SJ, Gillette E, et al. Radiotherapy of soft tissue sarcomas in dogs. JAVMA 1989;194:60-3.
46. Harvey HJ, MacEwen EG, Braun D, et al. Prognostic criteria for dogs with oral melanoma. JAVMA 1981;178:580-2.
47. MacEwen EG, Patnaik AK, Harvey HJ, et al. Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum. Cancer Invest 1986;4:397-402.
48. Bateman KE, Catton PA, Pennock PW, et al. Radiation therapy for the treatment of canine oral melanoma. J Vet Intern Med 1994;8:267-72.
49. Blackwood L, Dobson JM. Radiotherapy of oral malignant melanomas in dogs. JAVMA 1996;209:98-102.
50. Overly B, Goldschmidt M, Shofer F, et al. Canine oral melanoma: a retrospective study [abstract]. In: Proceedings of the 21st Annual Conference of the Veterinary Cancer Society, Baton Rouge. Spring Valley (CA): Veterinary Cancer Society; 2001. p. 43.
51. Proulx DR, Horn B, Ruslander DM, et al. Canine oral malignant melanoma: a retrospective analysis of 140 dogs treated with external beam radiation therapy (1984-2001) [abstract]. In: Proceedings of the 21st Annual Conference of the Veterinary Cancer Society. Baton Rouge. Spring Valley (CA): Veterinary Cancer Society: 2001. p. 45.
52. Dewhirst MW, Sim DA, Forsyth K, et al. Local control and distant metastases in primary canine malignant melanomas treated with hyperthermia and/or radiotherapy. Int J Hyperthermia 1985;1:219-34.
53. Thompson JM, Dhoodhat YA, Bleehen NM, et al. Microwave hyperthermia in the treatment of spontaneous canine tumours: an analysis of treatment parameters and tumour response. Int J Hyperthermia 1988;4:383-99.
54. Rassnick KM, Ruslander DM, Cotter SM, et al. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000). JAVMA 2001;218:1444-8.
55. MacEwen EG, Kurzman ID, Vail DM, et al. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide and granulocyte-macrophage colony-stimulating factor. Clin Cancer Res 1999;5:4249-58.
56. Dow SW, Elmslie RE, Willson AP, et al. In vivo transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. J Clin Invest 1998;101:2406-14.
57. Bergman PJ, McKnight JA, Novosad CA, et al. Phase I trial of human tyrosinase DNA vaccination in dogs with advanced malignant melanoma [abstract]. In: Proceedings of the 21st Annual Conference of the Veterinary Cancer Society, Baton Rouge. Spring Valley (CA): Veterinary Cancer Society; 2001. p. 47.
58. Straw RC, Powers BE, Klausner J, et al. Canine mandibular osteosarcoma: 51 cases (1980-1992). J Am Anim Hosp Assoc 1996;32:257-62.
59. Dernell WS, Van Vechten BJ, Straw RC, et al. Outcome following treatment for vertebral tumors in 20 dogs (1986-1995). J Am Anim Hosp Assoc 2000;36:245-51.
60. Theon AP, Rodriguez C, Madewell BR. Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation. JAVMA 1997;210:778-84.
61. Gillette EL. Radiation therapy of canine and feline tumors. J Am Anim Hosp Assoc 1976;12:359-62.
62. Evans SM, Shofer F. Canine oral nontonsillar squamous cell carcinoma. Prognostic factors for recurrence and survival following orthovoltage radiation therapy. Vet Radiol Ultrasound 1988;29:133-7.
63. LaDue-Miller TA, Price GS, Page RL, et al. Radiotherapy of canine non-tonsillar squamous cell carcinoma. Vet Radiol Ultrasound 1996;37:74-7.
64. Gillette EL, McChesney SL, Dewhirst MW, et al. Response of canine oral carcinomas to heat and radiation. Int J Radiat Oncol Biol Phys 1987;13:1861-7.
65. MacMillan R, Withrow SJ, Gillette EL. Surgery and regional irradiation for treatment of canine tonsillar squamous cell carcinoma: retrospective review of eight cases. J Am Anim Hosp Assoc 1982;18:311-4.
66. Brooks MB, Matus RE, Leffer CE, et al. Chemotherapy versus chemotherapy plus radiotherapy in the treatment of tonsillar squamous cell carcinoma in the dog. J Vet Intern Med 1988;2:206-11.
67. Postorino-Reeves NC, Turrell JM, Withrow SJ. Oral squamous cell carcinoma in the cat. J Am Anim Hosp Assoc 1993;29:438-41.
68. Hutson CA, Willauer CC, Walder EJ, et al. Treatment of mandibular squamous cell carcinoma in cats by use of mandibulectomy and radiotherapy: seven cases (1987-1989). JAVMA 1992;201:777-81.
69. Evans SM, LaCreta F, Helfand S, et al. Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1991;20:703-8.
70. Carberry CA, Glanders JA, Harvey HJ, et al. Salivary gland tumors in dogs and cats: a literature and case review. J Am Anim Hosp Assoc 1988;24:561-7.
71. Evans SM, Thrall DE. Postoperative orthovoltage radiation therapy of parotid salivary gland adenocarcinoma. in three dogs. JAVMA 1983;182:993-4.
72. Hammer A, Getzy D, Ogilvie G, et al. Salivary gland neoplasia in the dog and cat: survival times and prognostic factors. J Am Anim Hosp Assoc 2001;37:478-82.
73. London CA, Dubilzeig RR, Vail DM, et al. Evaluation of dogs and cats with tumors of the ear canal: 145 cases (1978-1992). JAVMA 1996;208:1413-8.
74. Marino DJ, MacDonald JM, Matthiesen DT, et al. Results of surgery and long-term follow-up in dogs with ceruminous gland adenocarcinoma. J Am Anim Hosp Assoc 1993;29:560-3.
75. Marino DJ, MacDonald JM, Matthiesen DT, et al. Results of surgery in cats with ceruminous gland adenocarcinoma. J Am Anim Hosp Assoc 1994;30:54-8.
76. Theon AP, Barthez PY, Madewell BR, et al. Radiation therapy of ceruminous gland carcinomas in dogs and cats. JAVMA 1994;205:566-9.
77. Klein MK, Powers BE, Withrow SJ, et al. Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989). JAVMA 1995;206:1007-9.
78. Theon AP, Marks SL, Feldman ES, et al. Prognostic factors and patterns of treatment failure in dogs with unresectable differentiated thyroid carcinomas treated with mega-voltage irradiation. JAVMA 2000;217:466-7.
79. Fineman LS, Hamilton TA, de Gortari A. Cisplatin chemotherapy for treatment of thyroid carcinoma in dogs: 13 cases. J Am Anim Hosp Assoc 1998;34:109-12.
80. Jeglum KA, Whereat A. Chemotherapy of canine thyroid carcinoma. Compend Contin Educ Pract Vet 1983;5:96-8.
81. Post GS, Mauldin GN. Radiation and adjuvant chemotherapy for the treatment of thyroid adenocarcinoma in dogs [abstract]. In: Proceedings of the 12th Annual Conference of the Veterinary Cancer Society. Spring Valley (CA): Veterinary Cancer Society; 1992. p. 43-4.
82. Mendelsohn J, Shin DM, Donato N, et al. The epidermal growth factor receptor as a target for cancer therapy. Endocr Relat Cancer 2001;8:3-9.
83. Shin DM, Donato NJ, Perez-Soler R, et al. Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clin Cancer Res 2001;7:1204-13.
84. Mazeron JJ, Noel G, Simon JM. Head and neck brachytherapy. Semin Radiat Oncol 2002;12:95-108.
85. Schwarz PD, Withrow SJ, Curtis CR, et al. Mandibular resection as a treatment of oral cancer in 81 does. J Am Anim Hosp Assoc 1991:27:601-10.
86. Schwarz PD, Withrow SJ, Curtis CR, et al. Partial maxillary resection as a treatment for oral cancer in 81 dogs. J Am Anim Hosp Assoc 1991;27:617-24.